929MO Platform study of neoadjuvant durvalumab (D) alone or combined with novel agents in patients (pts) with resectable, early-stage non-small cell lung cancer (NSCLC): Pharmacodynamic correlates and circulating tumor DNA (ctDNA) dynamics in the NeoCOAST study
| Autor: | Spicer, J., Cascone, T., Kar, G., Zheng, Y., Blando, J., Tan, T.H., Cheng, M., Mager, R., Hamid, O., Soo-Hoo, Y., Forde, P.M., Weder, W., Garcia Campelo, M.R., Grenga, I., Kumar, R., McGrath, L. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S971-S971 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|